TARS: Guggenheim Raises Price Target to $90, Maintains Buy Ratin - GuruFocus17 minutes ago • Google News
Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative - simplywall.st16 hours ago • Google News